MIR6876

Across TCGA pan-cancer cohorts, MIR6876 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MIR6876 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR6876 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR6876 expression acts as an unfavorable survival marker, although some lineages such as LUAD and BLCA show a favorable association.

LUAD, READ, and LIHC are the cancer types where MIR6876 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	II,III,IV	0.925	0.220	.007	90	view →
READ	OS	Tertile	All	0.164	0.703	<.001	72	view →
LIHC	OS	Tertile	All	0.178	0.707	.004	45	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	36	view →
LGG	DFS	Tertile	All	0.679	0.832	.005	24	view →
PAAD	OS	Tertile	All	0.211	0.471	.024	18	view →
KICH	DFS	Tertile	All	0.162	0.862	.014	15	view →
BLCA	DFS	Tertile	All	0.684	0.326	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MIR6876–LUAD (DFS)

Open the LUAD breakdown →